Phathom Pharmaceuticals, Inc. (PHAT) Share-based Payment Arrangement, Expense USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Phathom Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2024.
  • Phathom Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $5.63 M, a 20.2% decline year-over-year.
  • Phathom Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $43.6 M, a 71.6% increase year-over-year.
  • Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $45 M, a 86.6% increase from 2022.
  • Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $24.1 M, a 43.5% increase from 2021.
  • Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $16.8 M, a 188% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $43.6 M $5.63 M -$1.42 M -20.2% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-06-14
Q4 2023 $45 M $24.6 M +$17.9 M +269% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-06-14
Q3 2023 $27.1 M $6.14 M +$324 K +5.57% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $26.8 M $7.25 M +$1.37 M +23.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $25.4 M $7.05 M +$1.27 M +22% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-06-14
Q4 2022 $24.1 M $6.66 M +$2.32 M +53.5% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-06-14
Q3 2022 $21.8 M $5.82 M +$1.4 M +31.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $20.4 M $5.89 M +$1.65 M +38.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $18.8 M $5.78 M +$1.96 M +51.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $16.8 M $4.34 M +$1.96 M +82.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $14.9 M $4.42 M +$2.35 M +113% Jul 1, 2021 Sep 30, 2021 10-Q/A 2022-11-09
Q2 2021 $12.5 M $4.24 M +$3.41 M +412% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $9.1 M $3.82 M +$3.26 M +578% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $5.84 M $2.38 M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $2.07 M +$2.03 M +5495% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $828 K +$799 K +2755% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $563 K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $37 K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $29 K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.